Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDT NASDAQ:GH NYSE:HIMS NASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$15.23+2.8%$13.48$10.10▼$18.85$2.18B0.39341,973 shs400,831 shsGHGuardant Health$72.15+4.0%$62.25$20.14▼$72.70$9.00B1.532.00 million shs2.47 million shsHIMSHims & Hers Health$48.86+0.8%$51.14$18.33▼$72.98$11.03B2.2530.97 million shs16.01 million shsOPCHOption Care Health$27.91-0.5%$27.99$21.39▼$35.53$4.53B0.881.68 million shs1.10 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health0.00%+3.88%+15.34%+37.83%-21.01%GHGuardant Health0.00%+10.22%+19.89%+62.43%+253.33%HIMSHims & Hers Health0.00%-1.84%-11.08%-15.03%+128.57%OPCHOption Care Health0.00%+0.50%+4.06%-6.00%-7.12%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$15.23+2.8%$13.48$10.10▼$18.85$2.18B0.39341,973 shs400,831 shsGHGuardant Health$72.15+4.0%$62.25$20.14▼$72.70$9.00B1.532.00 million shs2.47 million shsHIMSHims & Hers Health$48.86+0.8%$51.14$18.33▼$72.98$11.03B2.2530.97 million shs16.01 million shsOPCHOption Care Health$27.91-0.5%$27.99$21.39▼$35.53$4.53B0.881.68 million shs1.10 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health0.00%+3.88%+15.34%+37.83%-21.01%GHGuardant Health0.00%+10.22%+19.89%+62.43%+253.33%HIMSHims & Hers Health0.00%-1.84%-11.08%-15.03%+128.57%OPCHOption Care Health0.00%+0.50%+4.06%-6.00%-7.12%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health 2.62Moderate Buy$19.3026.72% UpsideGHGuardant Health 2.92Moderate Buy$67.29-6.74% DownsideHIMSHims & Hers Health 1.93Reduce$38.92-20.34% DownsideOPCHOption Care Health 2.69Moderate Buy$35.1025.76% UpsideCurrent Analyst Ratings BreakdownLatest ARDT, HIMS, OPCH, and GH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/25/2025GHGuardant HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/25/2025OPCHOption Care HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/24/2025ARDTArdent HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)10/22/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$60.00 ➝ $90.0010/21/2025HIMSHims & Hers HealthKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageSector Weight10/17/2025OPCHOption Care HealthMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$35.0010/14/2025ARDTArdent HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$19.0010/14/2025ARDTArdent HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$19.0010/14/2025HIMSHims & Hers HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)10/8/2025ARDTArdent HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/8/2025GHGuardant HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health$5.97B0.37$2.54 per share6.00$10.66 per share1.43GHGuardant Health$739.02M12.18N/AN/A($1.13) per share-63.85HIMSHims & Hers Health$2.01B5.48$0.35 per share138.52$2.16 per share22.62OPCHOption Care Health$5.00B0.91$1.64 per share16.97$8.25 per share3.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health$210.34M$1.818.417.776.724.11%16.66%5.18%11/12/2025 (Estimated)GHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%10/29/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.8061.0793.953.389.63%26.26%13.06%11/3/2025 (Estimated)OPCHOption Care Health$211.82M$1.2522.3322.151.693.93%17.53%7.17%10/30/2025 (Estimated)Latest ARDT, HIMS, OPCH, and GH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/12/2025Q3 2025ARDTArdent Health$0.42N/AN/AN/A$1.55 billionN/A11/3/2025Q3 2025HIMSHims & Hers Health$0.09N/AN/AN/A$578.99 millionN/A10/30/2025Q3 2025OPCHOption Care Health$0.43N/AN/AN/A$1.41 billionN/A10/29/2025Q3 2025GHGuardant Health-$0.48N/AN/AN/A$235.72 millionN/A8/5/2025Q2 2025ARDTArdent Health$0.30$0.52+$0.22$0.52$1.54 billion$1.65 billion8/4/2025Q2 2025HIMSHims & Hers Health$0.18$0.17-$0.01$0.17$550.06 million$544.83 million7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 million7/30/2025Q2 2025OPCHOption Care Health$0.40$0.41+$0.01$0.31$1.35 billion$1.42 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent HealthN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health0.662.132.00GHGuardant HealthN/A3.713.35HIMSHims & Hers Health1.724.984.46OPCHOption Care Health0.811.521.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent HealthN/AGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipARDTArdent Health1.70%GHGuardant Health6.10%HIMSHims & Hers Health13.71%OPCHOption Care Health0.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health24,900143.11 million140.67 millionOptionableGHGuardant Health2,021124.71 million117.10 millionNot OptionableHIMSHims & Hers Health1,637226.02 million195.03 millionOptionableOPCHOption Care Health8,088162.29 million161.26 millionOptionableARDT, HIMS, OPCH, and GH HeadlinesRecent News About These CompaniesWeiss Ratings Reiterates "Hold (C)" Rating for Option Care Health (NASDAQ:OPCH)5 hours ago | marketbeat.comVIRGINIA RETIREMENT SYSTEMS ET Al Takes $348,000 Position in Option Care Health, Inc. $OPCHOctober 26 at 3:51 AM | marketbeat.comOption Care Health (OPCH): Exploring Valuation After This Year’s Share Price ReboundOctober 25 at 7:17 AM | finance.yahoo.comRep. Lisa C. McClain Purchases Shares of Option Care Health, Inc. (NASDAQ:OPCH)October 24 at 5:08 AM | marketbeat.comOption Care (OPCH) Earnings Expected to Grow: Should You Buy?October 23 at 11:07 AM | zacks.comOption Care Health (OPCH) to Release Quarterly Earnings on ThursdayOctober 23 at 4:17 AM | americanbankingnews.comOption Care Health (OPCH) Expected to Announce Quarterly Earnings on ThursdayOctober 23 at 3:42 AM | marketbeat.comCan Option Care (OPCH) Keep the Earnings Surprise Streak Alive?October 21, 2025 | zacks.comOption Care Health, Inc. (NASDAQ:OPCH) Given Consensus Rating of "Moderate Buy" by BrokeragesOctober 20, 2025 | marketbeat.comOption Care Health (OPCH) Stock Is Up, What You Need To KnowOctober 18, 2025 | msn.comMorgan Stanley Initiates Coverage of Option Care Health (OPCH) with Overweight RecommendationOctober 17, 2025 | msn.comOption Care Health initiated with an Overweight at Morgan StanleyOctober 17, 2025 | msn.comShould Value Investors Buy Option Care Health (OPCH) Stock?October 16, 2025 | zacks.comOption Care Health, Inc. $OPCH Shares Bought by Allspring Global Investments Holdings LLCOctober 15, 2025 | marketbeat.comBlair William & Co. IL Buys 31,821 Shares of Option Care Health, Inc. $OPCHOctober 15, 2025 | marketbeat.comOPCH or CHE: Which Is the Better Value Stock Right Now?October 14, 2025 | zacks.comCould The Market Be Wrong About Option Care Health, Inc. (NASDAQ:OPCH) Given Its Attractive Financial Prospects?October 12, 2025 | finance.yahoo.comVillere ST Denis J & Co. LLC Trims Position in Option Care Health, Inc. $OPCHOctober 11, 2025 | marketbeat.comOption Care Health (NASDAQ:OPCH) Given Hold (C) Rating at Weiss RatingsOctober 10, 2025 | marketbeat.comTD Cowen Initiates Coverage of Option Care Health (OPCH) with Hold RecommendationOctober 3, 2025 | msn.comOption Care Health initiated with a Hold at TD CowenOctober 2, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025October’s Top 5 Stocks Poised for Big BreakoutsBy Thomas Hughes | October 1, 2025Datavault AI: The New AI Contender Backed by Big FundingBy Jeffrey Neal Johnson | October 1, 20253 Healthcare Stocks Using AI to Drive GrowthBy Chris Markoch | September 27, 2025Hims & Hers Short Interest Nears All-Time High, Buy The Dip?By Gabriel Osorio-Mazilli | October 24, 2025ARDT, HIMS, OPCH, and GH Company DescriptionsArdent Health NYSE:ARDT$15.23 +0.42 (+2.84%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$15.21 -0.02 (-0.13%) As of 10/24/2025 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Guardant Health NASDAQ:GH$72.15 +2.80 (+4.04%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$72.22 +0.07 (+0.10%) As of 10/24/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$48.86 +0.37 (+0.75%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$49.20 +0.34 (+0.69%) As of 10/24/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$27.91 -0.13 (-0.46%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$27.91 0.00 (0.00%) As of 10/24/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 10/20 - 10/24 Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tractor Supply Stock Looks Like a Buy-and-Hold Winner Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Fal.Con Europe Could Be CrowdStrike’s Early Earnings Catalyst Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
